# Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months

> **NCT06399003** · PHASE3 · COMPLETED · sponsor: **Shanghai Institute Of Biological Products** · enrollment: 1200 (actual)

## Conditions studied

- Measles-Mumps-Rubella

## Interventions

- **BIOLOGICAL:** SIBP MMR Vaccine
- **BIOLOGICAL:** GSK MMR Vaccine (PRIORIX)
- **BIOLOGICAL:** Yellow Fever Vaccine (Stamaril)

## Key facts

- **NCT ID:** NCT06399003
- **Lead sponsor:** Shanghai Institute Of Biological Products
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-28
- **Primary completion:** 2024-09-15
- **Final completion:** 2025-03-10
- **Target enrollment:** 1200 (ACTUAL)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06399003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06399003, "Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06399003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*